Atherogenic mononuclear cell recruitment is facilitated by oxidized lipoprotein-induced endothelial junctional adhesion molecule-A redistribution

Atherosclerosis

Volumn 234, Issue 2, 2014, Pages 254-264

  Schmitt, Martin M N ^a,b,c   Fraemohs, Line ^b   Hackeng, Tilman M ^c   Weber, Christian ^a,c,d   Koenen, Rory R ^a,c  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

Atherosclerosis; Endothelial cells; F11R; JAM 1; Junctional adhesion molecule; Statin; Transmigration

Indexed keywords

JUNCTIONAL ADHESION MOLECULE A; MEVINOLIN; OXIDIZED LOW DENSITY LIPOPROTEIN; PIOGLITAZONE; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIINFLAMMATORY AGENT; APOLIPOPROTEIN E; AUTACOID; CELL ADHESION MOLECULE; CELL SURFACE RECEPTOR; F11R PROTEIN, HUMAN; F11R PROTEIN, MOUSE; LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; ARTICLE; ATTENUATION; CELL MEMBRANE PERMEABILITY; CELL STIMULATION; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE DELETION; HUMAN; HUMAN CELL; LEUKOCYTE ADHERENCE; MONOCYTE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RNA INTERFERENCE; T LYMPHOCYTE; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION; ANIMAL; ATHEROSCLEROSIS; CELL CULTURE; COCULTURE; DEFICIENCY; DRUG EFFECTS; GENETIC TRANSFECTION; GENETICS; INFLAMMATION; KNOCKOUT MOUSE; LEUKOCYTE ROLLING; METABOLISM; MOUSE; PATHOLOGY; PERMEABILITY; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CELL ADHESION MOLECULES; CELLS, CULTURED; COCULTURE TECHNIQUES; ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LEUKOCYTE ROLLING; LEUKOCYTES, MONONUCLEAR; LIPOPROTEINS, LDL; LOVASTATIN; MICE; MICE, KNOCKOUT; PERMEABILITY; PROTEIN TRANSPORT; RECEPTORS, CELL SURFACE; RNA INTERFERENCE; SIGNAL TRANSDUCTION; THIAZOLIDINEDIONES; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION; TRANSFECTION;

EID: 84900867201     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.03.014     Document Type: Article

References (37)

1. Bazzoni G., Dejana E. Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. Physiol Rev 2004, 84:869-901.
2. Laukoetter M.G., Nava P., Lee W.Y., et al. JAM-A regulates permeability and inflammation in the intestine invivo. JExp Med 2007, 204:3067-3076.
3. Ozaki H., Ishii K., Horiuchi H., et al. Combined treatment of TNF-alpha and IFN-gamma causes redistribution of junctional adhesion molecule in human endothelial cells. JImmunol 1999, 163:553-557.
4. Weber C., Fraemohs L., Dejana E. The role of junctional adhesion molecules in vascular inflammation. Nat Rev Immunol 2007, 7:467-477.
5. Woodfin A., Reichel C.A., Khandoga A., et al. JAM-A mediates neutrophil transmigration in a stimulus-specific manner invivo: evidence for sequential roles for JAM-A and PECAM-1 in neutrophil transmigration. Blood 2007, 110:1848-1856.
6. Ostermann G., Fraemohs L., Baltus T., et al. Involvement of JAM-A in mononuclear cell recruitment on inflamed or atherosclerotic endothelium: inhibition by soluble JAM-A. Arterioscler Thromb Vasc Biol 2005, 25:729-735.
7. Ostermann G., Weber K.S., Zernecke A., et al. JAM-1 is a ligand of the beta(2) integrin LFA-1 involved in transendothelial migration of leukocytes. Nat Immunol 2002, 3:151-158.
8. Cera M.R., Fabbri M., Molendini C., et al. JAM-A promotes neutrophil chemotaxis by controlling integrin internalization and recycling. JCell Sci 2009, 122:268-277.
9. Koenen R.R., Pruessmeyer J., Soehnlein O., et al. Regulated release and functional modulation of junctional adhesion molecule A by disintegrin metalloproteinases. Blood 2009, 113:4799-4809.
10. Cavusoglu E., Kornecki E., Sobocka M.B., et al. Association of plasma levels of F11 receptor/junctional adhesion molecule-A (F11R/JAM-A) with human atherosclerosis. JAm Coll Cardiol 2007, 50:1768-1776.
11. Babinska A., Azari B.M., Salifu M.O., et al. The F11 receptor (F11R/JAM-A) in atherothrombosis: overexpression of F11R in atherosclerotic plaques. Thromb Haemost 2007, 97:272-281.
12. Zernecke A., Liehn E.A., Fraemohs L., et al. Importance of junctional adhesion molecule-A for neointimal lesion formation and infiltration in atherosclerosis-prone mice. Arterioscler Thromb Vasc Biol 2006, 26:e10-e13.
13. Keiper T., Al-Fakhri N., Chavakis E., et al. The role of junctional adhesion molecule-C (JAM-C) in oxidized LDL-mediated leukocyte recruitment. FASEB J 2005, 19:2078-2080.
14. Schmitt M.M., Megens R.T., Zernecke A., et al. Endothelial JAM-A guides monocytes into flow-dependent predilection sites of atherosclerosis. Circulation 2014, 129:66-76.
15. Bazzoni G. The JAM family of junctional adhesion molecules. Curr Opin Cell Biol 2003, 15:525-530.
16. Kostrewa D., Brockhaus M., D'Arcy A., et al. X-ray structure of junctional adhesion molecule: structural basis for homophilic adhesion via a novel dimerization motif. EMBO J 2001, 20:4391-4398.
17. Wojcikiewicz E.P., Koenen R.R., Fraemohs L., et al. LFA-1 binding destabilizes the JAM-A homophilic interaction during leukocyte transmigration. Biophys J 2009, 96:285-293.
18. Bazzoni G., Martinez-Estrada O.M., Orsenigo F., et al. Interaction of junctional adhesion molecule with the tight junction components ZO-1, cingulin, and occludin. JBiol Chem 2000, 275:20520-20526.
19. Ebnet K., Schulz C.U., Meyer Zu Brickwedde M.K., et al. Junctional adhesion molecule interacts with the PDZ domain-containing proteins AF-6 and ZO-1. JBiol Chem 2000, 275:27979-27988.
20. Bruewer M., Luegering A., Kucharzik T., et al. Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. JImmunol 2003, 171:6164-6172.
21. Martinez-Estrada O.M., Manzi L., Tonetti P., et al. Opposite effects of tumor necrosis factor and soluble fibronectin on junctional adhesion molecule-A in endothelial cells. Am J Physiol Lung Cell Mol Physiol 2005, 288:L1081-L1088.
22. Jaczewska J., Abdulreda M.H., Yau C.Y., et al. TNF-alpha and IFN-gamma promote lymphocyte adhesion to endothelial junctional regions facilitating transendothelial migration. J Leukoc Biol 2014, 95:265-274.
23. Groeneweg M., Vergouwe M.N., Scheffer P.G., et al. Modification of LDL with oxidized 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholine (oxPAPC) results in a novel form of minimally modified LDL that modulates gene expression in macrophages. Biochim Biophys Acta 2008, 1781:336-343.
24. Kreisel D., Krupnick A.S., Szeto W.Y., et al. Asimple method for culturing mouse vascular endothelium. JImmunol Methods 2001, 254:31-45.
25. Schenkel A.R., Mamdouh Z., Muller W.A. Locomotion of monocytes on endothelium is a critical step during extravasation. Nat Immunol 2004, 5:393-400.
26. Fraemohs L., Koenen R.R., Ostermann G., et al. The functional interaction of the beta 2 integrin lymphocyte function-associated antigen-1 with junctional adhesion molecule-A is mediated by the I domain. JImmunol 2004, 173:6259-6264.
27. Babinska A., Kedees M.H., Athar H., et al. F11-receptor (F11R/JAM) mediates platelet adhesion to endothelial cells: role in inflammatory thrombosis. Thromb Haemost 2002, 88:843-850.
28. Ong K.L., Leung R.Y., Babinska A., et al. Elevated plasma level of soluble F11 receptor/junctional adhesion molecule-A (F11R/JAM-A) in hypertension. Am J Hypertens 2009, 22:500-505.
29. Xu H., Oliveira-Sales E.B., McBride F., et al. Upregulation of junctional adhesion molecule-A is a putative prognostic marker of hypertension. Cardiovasc Res 2012, 96:552-560.
30. Weber C., Noels H. Atherosclerosis: current pathogenesis and therapeutic options. Nat Med 2011, 17:1410-1422.
31. Ghosh-Choudhury N., Mandal C.C., Ghosh Choudhury G. Simvastatin induces derepression of PTEN expression via NFkappaB to inhibit breast cancer cell growth. Cell Signal 2010, 22:749-758.
32. Guijarro C., Kim Y., Schoonover C.M., et al. Lovastatin inhibits lipopolysaccharide-induced NF-kappaB activation in human mesangial cells. Nephrol Dial Transplant Official publication of the European Dialysis and Transplant Association - European Renal Association 1996, 11:990-996.
33. Cheshire J.L., Baldwin A.S. Synergistic activation of NF-kappaB by tumor necrosis factor alpha and gamma interferon via enhanced I kappaB alpha degradation and de novo I kappaBbeta degradation. Mol Cell Biol 1997, 17:6746-6754.
34. Robbesyn F., Salvayre R., Negre-Salvayre A. Dual role of oxidized LDL on the NF-kappaB signaling pathway. Free Radic Res 2004, 38:541-551.
35. Wu K., Tian S., Zhou H., et al. Statins protect human endothelial cells from TNF-induced inflammation via ERK5 activation. Biochem Pharmacol 2013, 85:1753-1760.
36. Xiao Y., Li Y., Han J., et al. Transgelin 2 participates in lovastatin-induced anti-angiogenic effects in endothelial cells through a phosphorylated myosin light chain-related mechanism. PloS One 2012, 7:e46510.
37. Hol J., Otterdal K., Breland U.M., et al. Statins affect the presentation of endothelial chemokines by targeting to multivesicular bodies. PloS One 2012, 7:e40673.